BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 31793351)

  • 1. The interaction of phages and bacteria: the co-evolutionary arms race.
    Safari F; Sharifi M; Farajnia S; Akbari B; Karimi Baba Ahmadi M; Negahdaripour M; Ghasemi Y
    Crit Rev Biotechnol; 2020 Mar; 40(2):119-137. PubMed ID: 31793351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revenge of the phages: defeating bacterial defences.
    Samson JE; Magadán AH; Sabri M; Moineau S
    Nat Rev Microbiol; 2013 Oct; 11(10):675-87. PubMed ID: 23979432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coevolution between bacterial CRISPR-Cas systems and their bacteriophages.
    Watson BNJ; Steens JA; Staals RHJ; Westra ER; van Houte S
    Cell Host Microbe; 2021 May; 29(5):715-725. PubMed ID: 33984274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CRISPR: discovery, mechanism and function.
    Pawluk A; Davidson AR; Maxwell KL
    Nat Rev Microbiol; 2018 Jan; 16(1):12-17. PubMed ID: 29062071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covalent Modifications of the Bacteriophage Genome Confer a Degree of Resistance to Bacterial CRISPR Systems.
    Liu Y; Dai L; Dong J; Chen C; Zhu J; Rao VB; Tao P
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32938767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance is not futile: bacterial 'innate' and CRISPR-Cas 'adaptive' immune systems.
    Fineran PC
    Microbiology (Reading); 2019 Aug; 165(8):834-841. PubMed ID: 30958259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meet the Anti-CRISPRs: Widespread Protein Inhibitors of CRISPR-Cas Systems.
    Hwang S; Maxwell KL
    CRISPR J; 2019 Feb; 2(1):23-30. PubMed ID: 31021234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diversity of molecular mechanisms used by anti-CRISPR proteins: the tip of an iceberg?
    Hardouin P; Goulet A
    Biochem Soc Trans; 2020 Apr; 48(2):507-516. PubMed ID: 32196554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why put up with immunity when there is resistance: an excursion into the population and evolutionary dynamics of restriction-modification and CRISPR-Cas.
    Gurney J; Pleška M; Levin BR
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180096. PubMed ID: 30905282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The functional aspects of bacterial CRISPR-cas systems and interactions between phages and its bacterial hosts--a review].
    Fu Q; Sun J; Yan Y
    Wei Sheng Wu Xue Bao; 2015 Mar; 55(3):251-7. PubMed ID: 26065266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keeping crispr in check: diverse mechanisms of phage-encoded anti-crisprs.
    Trasanidou D; Gerós AS; Mohanraju P; Nieuwenweg AC; Nobrega FL; Staals RHJ
    FEMS Microbiol Lett; 2019 May; 366(9):. PubMed ID: 31077304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abortive Infection: Bacterial Suicide as an Antiviral Immune Strategy.
    Lopatina A; Tal N; Sorek R
    Annu Rev Virol; 2020 Sep; 7(1):371-384. PubMed ID: 32559405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Anti-CRISPR Story: A Battle for Survival.
    Maxwell KL
    Mol Cell; 2017 Oct; 68(1):8-14. PubMed ID: 28985512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Discovery, Mechanisms, and Evolutionary Impact of Anti-CRISPRs.
    Borges AL; Davidson AR; Bondy-Denomy J
    Annu Rev Virol; 2017 Sep; 4(1):37-59. PubMed ID: 28749735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Significance of Mutualistic Phages for Bacterial Ecology and Evolution.
    Obeng N; Pratama AA; Elsas JDV
    Trends Microbiol; 2016 Jun; 24(6):440-449. PubMed ID: 26826796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms of CRISPR-mediated microbial immunity.
    Gasiunas G; Sinkunas T; Siksnys V
    Cell Mol Life Sci; 2014 Feb; 71(3):449-65. PubMed ID: 23959171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CRISPR proteins: Counterattack of phages on bacterial defense (CRISPR/Cas) system.
    Chaudhary K; Chattopadhyay A; Pratap D
    J Cell Physiol; 2018 Jan; 233(1):57-59. PubMed ID: 28247934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbial Arsenal of Antiviral Defenses. Part II.
    Isaev AB; Musharova OS; Severinov KV
    Biochemistry (Mosc); 2021 Apr; 86(4):449-470. PubMed ID: 33941066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phage-Encoded Anti-CRISPR Defenses.
    Stanley SY; Maxwell KL
    Annu Rev Genet; 2018 Nov; 52():445-464. PubMed ID: 30208287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploitation of the Cooperative Behaviors of Anti-CRISPR Phages.
    Chevallereau A; Meaden S; Fradet O; Landsberger M; Maestri A; Biswas A; Gandon S; van Houte S; Westra ER
    Cell Host Microbe; 2020 Feb; 27(2):189-198.e6. PubMed ID: 31901522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.